Merck halts testing of combination drug for lung cancer treatment
Merck said on Thursday it was halting a trial of a combination immunotherapy in patients with a type of lung cancer after an interim analysis showed the drug was unlikely to succeed.
ENTRADAS POPULARES
Poland prepares for peaking floods
septiembre 20, 2024
Italy evacuates thousands as Boris hits the north
septiembre 20, 2024
China and the US race to tame nuclear fusion for clean energy
septiembre 20, 2024
TRANSMISIÓN EN VIVO